Treatment of primary biliary cirrhosis

Minerva Gastroenterologica e Dietologica

Volumn 46, Issue 3, 2000, Pages 165-174

  Pares A ^a   Rodes J ^a  

^a HOSPITAL CLÍNIC   (Spain)

Author keywords

Biliary, diagnosis; Liver cirrhosis; Liver cirrhosis, biliary therapy

Indexed keywords

ALENDRONIC ACID; ALPHA TOCOPHEROL; BISPHOSPHONIC ACID DERIVATIVE; CALCIUM; COLCHICINE; COLESTYRAMINE; ETIDRONIC ACID; FLUORIDE SODIUM; METHOTREXATE; NALMEFENE; NALTREXONE; OPIATE ANTAGONIST; PREDNISONE; RETINOL; RIFAMPICIN; URSODEOXYCHOLIC ACID; VITAMIN D;

BONE MASS; CHOLESTASIS; CLINICAL TRIAL; DRUG EFFICACY; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; LIVER TRANSPLANTATION; MALABSORPTION; OSTEOPENIA; PATHOGENESIS; PLASMAPHERESIS; PRIMARY BILIARY CIRRHOSIS; PRURITUS; REVIEW; SYMPTOMATOLOGY;

EID: 0034477682     PISSN: 00264776     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (85)

1. ¿Es la cirrosis biliar primaria una enfermedad generalizada de tipo autoinimune?
2. Primary biliary cirrhosis
3. Epidemiología de la cirrosis biliar primaria en Cataluña
4. Familial primary biliary cirrhosis
5. Primary biliary cirrhosis
6. Staging of chronic non-suppurative destructive cholangitis (syndrome of primary biliary cirrhosis)
7. Bacteriuria and primary biliary cirrhosis
8. Sera from patients with tuberculosis recognize the M2a-epitope (E2-subunit of pyruvate dehydrogenase) specific for primary biliary cirrhosis
9. Antibodies against the COOH-terminal region of E. coli ClpP protease in patients with primary biliary cirrhosis
10. Are infectious agents involved in primary biliary cirrhosis? A PCR approach
11. Cross-reactivity of anti-mycobacterium gordonae antibodies with the major mitochondrial autoantigens in primary biliary cirrhosis
12. Cirrosis biliar primitiva asintomática
13. Clinical pattern and course of disease in primary biliary cirrhosis based on an analysis of 236 patients
14. Cirrosis biliar primaria. Evolución clínica y criterios de valor pronóstico
15. Antimitochondrial antibodies in primary biliary cirrhosis
16. Heterogeneity of antimitochondrial antigens
17. Autoantibodies against nuclear envelope-associated proteins in primary biliary cirrhosis
18. Lymphocytotoxic antibodies in primary biliary cirrhosis
19. Relief of the pruritus of jaundice with a bile acid sequestering resin
20. Effect of cholestyramine on bile acid metabolism in normal man
21. Timing of cholestyramine doses in cholestasic liver disease
22. Phenobarbital effects in cholestatic liver diseases
23. Comparison of rifamipicin with phenobarbitone for treatment of pruritus in biliary cirrhosis
24. Effects of long-term rifampicin administration in primary biliary cirrhosis
25. Effect of rifampicin in the treatment of pruritus in hepatic cholestasis
26. Treatment of pruritus of primary biliary cirrhosis with rifampicin
27. A controlled trial of naloxone infusions for the pruritus of cholestasis
28. Subhypnotic doses of propofol relieve pruritus associated with liver disease
29. S-adenosylmethionine for the treatment of intrahepatic cholestasis of pregnancy. Results of a controlled clinical trial
30. Open-label trial of oral malmefene therapy for the pruritus of cholestasis
31. Oral naltrexone treatment for cholestatic pruritus: A double-blind, placebo-controlled study
32. Utilidad del recambio plasmático intermitente en la cirrosis biliar primaria
33. Osteoporosis in primary biliary cirrhosis: Effects of 25-hydroxyvitamin D3 treatment
34. Fat-soluble vitamin nutriture in primary biliary cirrhosis
35. Intestinal malabsorption of vitamin E in primary biliary cirrhosis
36. Prevalence and prediction of osteopenia in chronic liver disease
37. Sodium fluoride prevents bone loss in primary biliary cirrhosis
38. Factors influencing the development of metabolic bone disease in primary biliary cirrhosis
39. Etidronate versus fluoride for treatment of osteopenia in primary biliary cirrhosis: Preliminary results after 2 years
40. Alendronate is more effective than etidronate for increasing bone mas in osteopneic partients with primary biliary cirrhosis
41. Cyclical etidronate in the prevention of bone loss in corticosteroid-treated primary biliary cirrhosis. A prospective, controlled pilot study
42. Parenteral calcitonin for metabolic bone disease associated with primary biliary cirrhosis
43. Hepatic osteodystrophy in primary biliary cirrhosis. Effects of medical treatment
44. A pilot, double-blind, controlled 1-year trial of prednisolone treatment in primary biliary cirrhosis: Hepatic improvement but greater bone loss
45. A controlled trial of prednisolone treatment in primary biliary cirrhosis: Three-year results
46. Oral budesonide and ursodeoxycholic acid for treatment of primary biliary cirrhosis: Results of a prospective double-blind trial
47. Oral budesonide in the treatment of patients with primary biliary cirrhosis with a suboptimal response to ursodeoxycholic acid
48. Beneficial effect of azathioprine and prediction of prognosis in primary biliary cirrhosis: Final results of an international trial
49. Trial of penicillamine in advanced primary biliary cirrhosis
50. A prospective trial of colchicine for primary biliary cirrhosis
51. Long-term follow up of patients with primary biliary cirrhosis on colchicine therapy
52. A controlled trial of cyclosporine in the treatment of primary biliary cirrhosis
53. Cyclosporin A treatment in primary biliary cirrhosis: Results of a long-term placebo controlled trial
54. Treatment of primary biliary cirrhosis with low-dose weekly methotrexate
55. Low-dose methotrexate in primary biliary cirrhosis: Long-term results of a placebo-controlled trial
56. Quantitative estimation of the hydrophilic-hydrophobic balance of mixed bile salt solutions
57. Ursodeoxycholate reduces hepatotoxicity of bile salts in primary human hepatocytes
58. Hypercholeresis induced by ursodeoxycholic acid and 7-ketolithocholic acid in the rat: Possible role of bicarbonate transport
59. Molecular aspects of membrane stabilization by ursodeoxycholate
60. Hepatic expression of class I and class II major histocompatibility complex molecules in primary biliary cirrhosis: Effect of ursodeoxycholic acid
61. Immunomodulating effect of ursodeoxycholic acid therapy in patients with primary biliary cirrhosis
62. Is ursodeoxycholic acid an effective treatment for primary biliary cirrhosis?
63. A multicenter, controlled trial of ursodiol for the treatment of primary biliary cirrhosis
64. The Canadian multicenter double-blind randomized controlled trial of ursodeoxycholic acid in primary biliary cirrhosis
65. Ursodeoxycholic acid in the treatment of primary biliary cirrhosis
66. Ursodiol for the long-term treatment of primary biliary cirrhosis
67. A randomized, double-blind, placebo controlled trial of ursodeoxycholic acid in primary biliary cirrhosis
68. Combined analysis of randomized controlled trials of ursodeoxycholic acid in primary biliary cirrhosis
69. Long-term effects of ursodeoxycholic acid in primary biliary cirrhosis. Results of a double blind randomized trial
70. Progression of primary biliary cirrhosis on ursodeoxycholic acid
71. Progression of primary biliary cirrhosis with ursodeoxycholic acid therapy
72. Randomised controlled trials of ursodeoxycholic acid therapy for primary biliary cirrhosis: A meta-analysis
73. Histopathological study of primary biliary cirrhosis and the effect of ursodexoycholic progression
74. Long-term ursodeoxycholic acid delays histological progression in primary biliary cirrhosis
75. The combination of ursodeoxycholic acid and methotrexate for patients with primary biliary cirrhosis: The results of a pilot study
76. A multicenter, controlled trial comparing colchicine and ursodeoxycholic acid combination to ursodeoxycholic acid in primary biliary cirrhosis
77. Combined treatment with ursodeoxycholic acid and prednisone in primary biliary cirrhosis
78. Consensus statement on indications for liver transplantation
79. Efficacy of liver transplantation in patients with primary biliary cirrhosis
80. Transplantation for primary biliary cirrhosis
81. Liver transplantation for primary biliary cirrhosis
82. Rates of vertebral bone loss before and after liver transplantation in women with primary biliary cirrhosis
83. Bone disease after liver transplantation. A three-year prospective study
84. Histological evidence for recurrence of primary biliary cirrhosis after liver transplantation
85. Primary biliary cirrhosis. Histological evidence of disease recurrence after liver transplantation